It is used to treat complicated urinary tract infections, complicated abdominal infections, and hospital-acquired pneumonia. In a study of 545 adults with complicated urinary tract infections, 98 percent of adults treated with Vabomere compared with about 94 percent of adults treated with piperacillin/tazobactam were cured defined as improvement in symptoms and a negative urine culture. About seven days after completing treatment, roughly 77 percent of adults treated with Vabomere compared with about 73 percent of those treated with piperacillin/tazobactam had resolved symptoms and a negative urine culture. Children Successful bacteremia clearance in a child has been reported using a<unk>  dose of 40 mg/kg every 6 hours given over 3 hours. It attained 100% of<unk>  serum concentrations above the minimum inhibitory concentration for at least 40% of the dosing interval.
Meropenem/vaborbactam
Ethambutol/isoniazid/rifampicin
Neomycin/polymyxin B/bacitracin
Fosfomycin/tobramycin
Ethambutol/isoniazid/pyrazinamide/rifampicin
Isoniazid/rifampicin
Ethambutol/isoniazid
Imipenem/cilastatin/relebactam